LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats

Photo from wikipedia

Highlights • Common etiology for carbamazepine (CBZ) toxicity is coadministration of other medications such as levetiracetam (LEV).• Adjuvant use of antiepileptic drugs with varying mechanisms of action is the mainstay… Click to show full abstract

Highlights • Common etiology for carbamazepine (CBZ) toxicity is coadministration of other medications such as levetiracetam (LEV).• Adjuvant use of antiepileptic drugs with varying mechanisms of action is the mainstay in refractory epilepsy management.• This study showed that neither CBZ, nor LEV treatment is devoid of hepatotoxicity.• The adverse effects in CBZ were greater than LEV, or CBZ + LEV adjunctive treatment.

Keywords: carbamazepine; adjunctive treatment; assessment biomarkers; carbamazepine levetiracetam; hepatotoxicity

Journal Title: Toxicology Reports
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.